FDA Classifies Blood Collection Device for Cell-Free Nucleic Acids into Class II Special Controls

Summary

The FDA has classified the blood collection device for cell-free nucleic acids into Class II special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.